Isoenzymes of carbohydrate metabolism in primary cultures of hepatocytes from thioacetamide-induced rat liver necrosis: responses to growth factors.
Hepatocytes isolated from the liver of rats after a necrotizing dose of thioacetamide (6.6 mmol/kg) were used to study the postnecrotic process of liver regeneration. Flow cytometry analysis revealed populations of dedifferentiated hepatocytes exhibiting physical properties (size and fluorescence emission at 530 nm) similar to those found in fetal (22 days old) liver cells. The percentage of these cells increased progressively from 24 to 48 and 72 hr after thioacetamide administration. In primary cultures of hepatocytes the effects of phorbol 12-myristate 13-acetate, bombesin and insulin were investigated on the 6-phosphofructo 2-kinase/fructose 2,6 bisphosphate system. Bombesin and insulin stimulated 6-phosphofructo 2-kinase activity and fructose 2,6-bisphosphate content both in control and in thioacetamide-treated hepatocytes. However, phorbol 12-myristate 13-acetate stimulated 6-phosphofructo 2-kinase activity and increased fructose 2,6-bisphosphate concentration in thioacetamide-treated liver cells, whereas no similar response was found in hepatocytes from control rats. The response of postnecrotic thioacetamide-treated hepatocytes to phorbol 12-myristate 13-acetate was similar to that obtained from 22-day-old fetal liver cells, which reveals that different methods might control fructose 2,6-bisphosphate content and therefore the mechanisms of glycolysis and gluconeogenesis at this regulatory step. The lack of response to glucagon of glycogen phosphorylase a and 6-phosphofructo 2-kinase from thioacetamide-treated hepatocytes may indicate that the expression of specific enzymes of carbohydrate metabolism undergoes transitions to less-differentiated isoenzymatic forms. Moreover, the isoenzyme pattern of hexokinases elicits a complete disturbance in glucokinase and hexokinases activities.(ABSTRACT TRUNCATED AT 250 WORDS)
Cascales
M
M
Instituto de Bioquimica, Facultad de Farmacia, Ciudad Universitaria, Madrid, Spain.
Martin-Sanz
P
P
Alvarez
A
A
Sanchez-Pérez
M
M
Diez Fernández
C
C
Boscá
L
L
D000818:Animals; D001839:Bombesin / Q000494:pharmacology; D050260:Carbohydrate Metabolism; D002478:Cells, Cultured; D005333:Fetus; D005635:Fructosediphosphates / Q000378:metabolism; D005934:Glucagon / Q000494:pharmacology; D006133:Growth Substances / Q000494:pharmacology*; D007328:Insulin / Q000494:pharmacology; D007527:Isoenzymes / Q000378:metabolism*; D008099:Liver / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology*; D008112:Liver Glycogen / Q000378:metabolism; D008297:Male; D009336:Necrosis; D025481:Phosphofructokinase-2; D010762:Phosphorylase a / Q000378:metabolism*; D010770:Phosphotransferases / Q000378:metabolism*; D011494:Protein Kinases / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013853:Thioacetamide / Q000633:toxicity*
D005635:Fructosediphosphates; D006133:Growth Substances; D007328:Insulin; D007527:Isoenzymes; D008112:Liver Glycogen; D013853:Thioacetamide; C027652:fructose 2,6-diphosphate; D005934:Glucagon; D010762:Phosphorylase a; D010770:Phosphotransferases; D011494:Protein Kinases; D025481:Phosphofructokinase-2; D013755:Tetradecanoylphorbol Acetate; D001839:Bombesin